Completion Target Date definition

Completion Target Date has the meaning set forth in Section 18.7.1.
Sample 1Sample 2
Completion Target Date means December 31, 2020.
Sample 1Sample 2
Completion Target Date means the 67th consecutive scheduled Trading Day from and including the Commencement Date.
Sample 1

Examples of Completion Target Date in a sentence

  • Landlord shall use commercially reasonable efforts to "Substantially Complete" the Landlord's Work not later than ________, 20________ (the "Substantial Completion Target Date").

  • Landlord shall have no liability whatsoever to Tenant in the event that Landlord shall fail for any reason whatsoever to Substantially Complete Landlord's Work on or before the Substantial Completion Target Date (including, without limitation, for any damages that Tenant may suffer as a result thereof or in connection therewith); provided, however, in such event, Landlord shall use commercially reasonable efforts to Substantially Complete Landlord's Work as soon as possible thereafter.

  • PLEASE PRINT OR TYPE Employee Name: CWID: Job Title and Division/Department: Credential/Training: Credential/Training for (specific areas/disciplines): Completion Target Date: Total Cost: (reimbursement for travel costs are required to go through Workday) Employee Signature Date FACULTY/STAFF: Submit form to supervisor and obtain final approval before beginning any work required to obtain credential/training.

  • The Parties agree to amend the terms of the Completion Test, as determined appropriate by each, acting commercially reasonably, in connection with the adoption of any Commingling Plan prior to the Completion Target Date.

  • Each of Customer and Cowen hereby consents to receiving all communications and notices from the other party electronically.

  • PLEASE PRINT OR TYPE Employee Name: CWID: Job Title and Division/Department: Credential/Training: Credential/Training for (specific areas/disciplines): Completion Target Date: Total Cost: (reimbursement of travel costs to be requested through Concur) Employee Signature Date FACULTY/STAFF: Submit form to supervisor and obtain final approval before beginning any work required to obtain credential/training.

  • For purposes of meeting the Completion Target Date, Sections 4.3 and 4.4 of this Agreement shall apply to both Tesla and any Toolmaker utilized by Tesla.

  • For purposes of meeting the Completion Target Date, Section 2.7 of these Terms and Conditions shall apply to both Supplier and any Toolmaker utilized by Supplier.

  • Project Co will keep the Interface Committee informed of all material changes to the Project Schedule, including changes to the SC1 Substantial Completion Target Date and the SC2 Substantial Completion Target Date.

  • A Change Order shall not be regarded as confirming an extension to the Milestone Payment Target Date or Substantial Completion Target Date unless expressly stipulated.


More Definitions of Completion Target Date

Completion Target Date means the completion date stated in the Engineering Contract (Additional Contract Data, Part One) as at the date that contract is entered into or such later date as is fixed under Clause 20 (Time for completion of the Infrastructure Works ).
Sample 1

Related to Completion Target Date

  • Target Date means the date specified as such in the Quote, subject to any variation of that date in accordance with clause 7.6.

  • Effectiveness Target Date As defined in Section 5.

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • project completion period means the period of sixty (60) months commencing from and expiring on for the construction and obtaining of Temporary Occupation Permit or Permits for the whole of the Development as provided in clause 3.3;

  • Milestone Event has the meaning set forth in Section 8.2.1.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Completion Deadline means the date by which the Arrangement is to be completed, which date shall be April 30, 2014 or such later date as may be agreed to in writing by the Parties;

  • Project Completion Date means the date on which the Completion Certificate is issued;

  • Completion Period means the period starting from the date of issue of "Order" and required to complete the work in all respect.

  • Target Completion Date has the meaning given such term in Section 3.3(b).

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • COMPLETION TIME means the period by ‘date/month’ specified in the ‘Letter of Intent/Award’ or date mutually agreed upon for handing over of the intended scope of work, the erected equipment/plant which are found acceptable by the Engineer, being of required standard and conforming to the specifications of the Contract.

  • Milestone Events has the meaning set forth in Section 7.2.

  • Development Milestone is defined in Section 5.3.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.